SYMPHONY.BOSYMPHONY.BOBSE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+15.5%
5Y CAGR+3.3%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+15.5%/yr
vs -7.3%/yr prior
5Y CAGR
+3.3%/yr
Recent acceleration
Acceleration
+22.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$3.11B+42.2%
2024$2.19B+15.1%
2023$1.90B-5.9%
2022$2.02B+22.7%
2021$1.65B-37.7%
2020$2.64B+78.7%
2019$1.48B-46.0%
2018$2.74B+12.9%
2017$2.43B+9.5%
2016$2.21B-